Analyses of FBXO28 mRNA expression in various malignant tissues using the in silico transcriptomics database of the GeneSapiens System (http://www.genesapiens.org) demonstrated elevated levels in several different tumour types, including breast cancer, gynecological tumours, sarcomas and neuronal tumours (Fig 7A). This evidence concerns the gene FBXO28 and sarcoma.